Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients
Susan Nowell(Roswell Park Comprehensive Cancer Center), Christine B. Ambrosone(Memorial Sloan Kettering Cancer Center), A Trovato(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carol Sweeney(University of Utah), Joshua O. Scheys(University of Michigan), Fred F. Kadlubar(Courtauld Institute of Art), Stewart L. MacLeod(University of Arkansas for Medical Sciences), Jiyoung Ahn(NYU Langone Health), James M. Rae(University of Michigan)
Cited by 306
Related Papers
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
Metabolic gene polymorphism frequencies in control populations.
|PubMed|2001|847
Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.
|Proceedings of the National Academy of Sciences|1989|638